Debate erupts over off-label COVID-19 vaccine use for children under the age of five

February 20, 2022

Debate erupts over off-label COVID-19 vaccine use for children under the age of five
By Shiv Sudhakar

After the federal Food and Drug Administration (FDA) delayed authorization of the Pfizer-BioNTech COVID-19 vaccine last week for children under the age of five in the United States, parents are making a passionate plea for its off-label use.